Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	49.55M	46.36M	89.68M	90.90M	—
Market Cap Growth	-25.0%	-48.3%	-1.3%	—	—
Enterprise Value	61.16M	59.15M	98.22M	97.40M	—
Last Close Price	32.60	30.50	59.00	59.80	—
Valuation Multiples
PE Ratio	60.47	56.57	509.93	132.51	—
PS Ratio	0.67	0.62	1.46	1.48	—
PB Ratio	2.11	1.97	3.96	4.06	—
P/TBV Ratio	2.13	1.99	4.03	4.15	—
P/FCF Ratio	12.88	12.05	81.55	91.19	—
P/OCF Ratio	8.51	7.96	18.09	15.73	—
EV/Sales Ratio	0.82	0.80	1.60	1.59	—
EV/EBITDA Ratio	11.96	18.12	48.53	32.66	—
EV/EBIT Ratio	40.33	39.01	256.62	62.66	—
EV/FCF Ratio	15.90	15.37	89.31	97.71	—
Leverage & Capital
Debt / Equity Ratio	0.51	0.51	0.38	0.48	0.32
Debt / EBITDA Ratio	2.33	2.33	2.05	2.04	1.45
Debt / FCF Ratio	3.10	3.10	7.86	10.73	—
Net Debt / Equity Ratio	0.49	0.49	0.35	0.44	0.26
Net Debt / EBITDA Ratio	3.56	3.56	3.89	3.30	1.68
Net Debt / FCF Ratio	3.02	3.02	7.16	9.87	-9.51
Efficiency & Liquidity
Asset Turnover	1.58	1.58	1.42	1.39	1.27
Inventory Turnover	2.63	2.63	2.23	1.98	1.84
Quick Ratio	0.24	0.24	0.26	0.14	0.19
Current Ratio	1.47	1.47	1.92	1.79	2.07
Returns & Yields
Return on Equity (ROE)	+3.6%	+3.6%	+0.8%	+3.0%	+8.4%
Return on Assets (ROA)	+2.0%	+2.0%	+0.6%	+2.2%	+3.9%
Return on Invested Capital (ROIC)	+3.3%	+3.5%	+0.4%	+3.2%	+8.1%
Return on Capital Employed (ROCE)	+4.5%	+4.5%	+1.3%	+5.0%	+8.6%
Earnings Yield	+1.7%	+1.8%	+0.2%	+0.8%	—
FCF Yield	+7.8%	+8.3%	+1.2%	+1.1%	—
Dividend Yield	+5.3%	—	—	+2.7%	—
Payout Ratio	—	—	—	+351.7%	+93.8%
Total Shareholder Return	+5.2%	—	—	+2.7%	—

ALRAZI

Al Razi Medical Company

9572StocksTadawulConsumer DiscretionaryMarket closed

SAR 27.30

Official close

-0.7%

Price as of August 6, 2026 · Market close

Prices may be delayed by up to 30 minutes.

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	49.55M	46.36M	89.68M	90.90M	—
Market Cap Growth	-25.0%	-48.3%	-1.3%	—	—
Enterprise Value	61.16M	59.15M	98.22M	97.40M	—
Last Close Price	32.60	30.50	59.00	59.80	—
Valuation Multiples
PE Ratio	60.47	56.57	509.93	132.51	—
PS Ratio	0.67	0.62	1.46	1.48	—
PB Ratio	2.11	1.97	3.96	4.06	—
P/TBV Ratio	2.13	1.99	4.03	4.15	—
P/FCF Ratio	12.88	12.05	81.55	91.19	—
P/OCF Ratio	8.51	7.96	18.09	15.73	—
EV/Sales Ratio	0.82	0.80	1.60	1.59	—
EV/EBITDA Ratio	11.96	18.12	48.53	32.66	—
EV/EBIT Ratio	40.33	39.01	256.62	62.66	—
EV/FCF Ratio	15.90	15.37	89.31	97.71	—
Leverage & Capital
Debt / Equity Ratio	0.51	0.51	0.38	0.48	0.32
Debt / EBITDA Ratio	2.33	2.33	2.05	2.04	1.45
Debt / FCF Ratio	3.10	3.10	7.86	10.73	—
Net Debt / Equity Ratio	0.49	0.49	0.35	0.44	0.26
Net Debt / EBITDA Ratio	3.56	3.56	3.89	3.30	1.68
Net Debt / FCF Ratio	3.02	3.02	7.16	9.87	-9.51
Efficiency & Liquidity
Asset Turnover	1.58	1.58	1.42	1.39	1.27
Inventory Turnover	2.63	2.63	2.23	1.98	1.84
Quick Ratio	0.24	0.24	0.26	0.14	0.19
Current Ratio	1.47	1.47	1.92	1.79	2.07
Returns & Yields
Return on Equity (ROE)	+3.6%	+3.6%	+0.8%	+3.0%	+8.4%
Return on Assets (ROA)	+2.0%	+2.0%	+0.6%	+2.2%	+3.9%
Return on Invested Capital (ROIC)	+3.3%	+3.5%	+0.4%	+3.2%	+8.1%
Return on Capital Employed (ROCE)	+4.5%	+4.5%	+1.3%	+5.0%	+8.6%
Earnings Yield	+1.7%	+1.8%	+0.2%	+0.8%	—
FCF Yield	+7.8%	+8.3%	+1.2%	+1.1%	—
Dividend Yield	+5.3%	—	—	+2.7%	—
Payout Ratio	—	—	—	+351.7%	+93.8%
Total Shareholder Return	+5.2%	—	—	+2.7%	—